S
Description
Sartar Therapeutics is a Finnish startup developing precision medicines for soft-tissue tumors. Its lead candidate SAR003 is a first-in-class targeted therapy for GIST with Orphan Drug Designation from EMA and FDA. Raised €2.3M seed funding in 2020.